4
Changes in Ownership
Anixa Biosciences Inc Filed Acc 0001493152-23-026125
Chief Executive Officer sold 11,800 shares at $3.57 ($42,126)
- Chief Executive Officer gave up 28,375 shares (to pay taxes)
- Chief Executive Officer acquired 40,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
KUMAR AMIT · Chief Executive Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-07-28 | Exercise or conversion : show line 1 in the form | +40,000 | $2.58 | $103,000 | 502,100 | D |
| 2023-07-28 | Shares withheld for taxes : show line 2 in the form | −28,375 | $3.63 | $103,001 | 473,725 | D |
| 2023-07-31 | Sale : show line 3 in the form | −11,800 | $3.57 | $42,126 | 461,925 | D |
| Open-market sales · 11,800 sh · avg $3.57 · $42,126 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-07-28 | Exercise or conversion : show line 4 in the form Employee Stock Option (Right to Buy) | −40,000 | 0 | D |
Loading xslF345X05/ownership.xml…